ONCOBLAZE LLC

Biotech · Private

Heat-sensitive lipid nanoparticles that encapsulate and deliver chemotherapy drugs to surgical sites when exposed to fever-range temperatures

Grants
$649K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
2
0 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · STTR Phase I: Preventing Tumor Recurrence by Heat-Triggered Drug Delivery$275,000
Federal grantDepartment of Health and Human Services · Phase I · Laser-guided drug delivery to prevent tumor recurrences$374,095
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2403Alchemab——
2404ARTEMIS BIOTECHNOLOGIES LLC——
2405MARK THERAPEUTICS, INC.——
2406ONCOBLAZE LLC——
2407INNOVIMMUNE BIOTHERAPEUTICS HOLDING, LLC——
2408FLIK THERAPEUTICS, INC.——
2409AXENT BIOSCIENCES INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 2
  • Method and Apparatus for Drug Delivery to Surgical Marginsapplication
  • Method And Apparatus For Drug Delivery To Surgical Marginsapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.